|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Shire_plc
|
|
gptkbp:acquisitionYear
|
2019
|
|
gptkbp:CEO
|
gptkb:Christophe_Weber
|
|
gptkbp:country
|
gptkb:Japan
|
|
gptkbp:founded
|
1781
|
|
gptkbp:founder
|
gptkb:Chobei_Takeda_I
|
|
gptkbp:globalPresence
|
over 80 countries
|
|
gptkbp:headquarters_location
|
gptkb:Nihonbashi,_Chuo-ku,_Tokyo,_Japan
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Takeda (Japan)
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:listedOn
|
gptkb:Nikkei_225
gptkb:TOPIX_Core30
|
|
gptkbp:notableProduct
|
gptkb:Livalo
gptkb:Alunbrig
gptkb:Cinryze
gptkb:Rozerem
gptkb:Brintellix
gptkb:Trintellix
gptkb:Tapros
gptkb:Adcetris
gptkb:Actos
gptkb:Azilva
gptkb:Blopress
gptkb:Colcrys
gptkb:Dexilant
gptkb:Ebrantil
gptkb:Edarbi
gptkb:Edarbyclor
gptkb:Entyvio
gptkb:Firazyr
gptkb:Gammagard
gptkb:Lupron
gptkb:Natpara
gptkb:Nesina
gptkb:Ninlaro
gptkb:Oseni
gptkb:Takhzyro
gptkb:Uloric
gptkb:Velcade
gptkb:Vpriv
gptkb:Vyvanse
Takecab
Takepron
Advate
Elaprase
Feiba
Replagal
Amitiza
Campto
Cuvitru
Leuplin
Liovel
Lotriga
Zafatek
|
|
gptkbp:numberOfEmployees
|
~49,000
|
|
gptkbp:products
|
vaccines
pharmaceutical drugs
plasma-derived therapies
gastroenterology medicines
oncology medicines
rare diseases medicines
|
|
gptkbp:R&D_focus
|
neuroscience
oncology
vaccines
gastroenterology
rare diseases
plasma-derived therapies
|
|
gptkbp:revenue
|
3.569 trillion yen (FY2022)
|
|
gptkbp:stockExchange
|
gptkb:Tokyo_Stock_Exchange
|
|
gptkbp:stockSymbol
|
4502
|
|
gptkbp:subsidiary
|
gptkb:ARIAD_Pharmaceuticals
gptkb:Millennium_Pharmaceuticals
gptkb:Nycomed
gptkb:Shire_plc
gptkb:TiGenix
|
|
gptkbp:website
|
https://www.takeda.com/
|
|
gptkbp:bfsParent
|
gptkb:Novavax_COVID-19_vaccine
|
|
gptkbp:bfsLayer
|
5
|